| Downregulation of transcription factor Oct4 induces an epithelial-to-mesenchymal transition via enhancement of Ca2+ influx in breast cancer cells J Hu, K Qin, Y Zhang, J Gong, N Li, D Lv, R Xiang, X Tan Biochemical and biophysical research communications 411 (4), 786-791, 2011 | 151 | 2011 |
| ZNF410 uniquely activates the NuRD component CHD4 to silence fetal hemoglobin expression X Lan, R Ren, R Feng, LC Ly, Y Lan, Z Zhang, N Aboreden, K Qin, ... Molecular cell 81 (2), 239-254. e8, 2021 | 57 | 2021 |
| The HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression P Huang, SA Peslak, X Lan, E Khandros, JA Yano, M Sharma, CA Keller, ... Blood, The Journal of the American Society of Hematology 135 (24), 2121-2132, 2020 | 51 | 2020 |
| SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice K Qin, N Zhang, Z Zhang, M Nipper, Z Zhu, J Leighton, K Xu, N Musi, ... Diabetologia 61, 906-918, 2018 | 43 | 2018 |
| Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation L Shen, K Qin, D Wang, Y Zhang, N Bai, S Yang, Y Luo, R Xiang, X Tan Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (11 …, 2014 | 32 | 2014 |
| Negative elongation factor controls energy homeostasis in cardiomyocytes H Pan, K Qin, Z Guo, Y Ma, C April, X Gao, TG Andrews, A Bokov, J Zhang, ... Cell reports 7 (1), 79-85, 2014 | 28 | 2014 |
| HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription P Huang, SA Peslak, R Ren, E Khandros, K Qin, CA Keller, B Giardine, ... Nature genetics 54 (9), 1417-1426, 2022 | 18 | 2022 |
| Efficient engineering of human and mouse primary cells using peptide-assisted genome editing Z Zhang, AE Baxter, D Ren, K Qin, Z Chen, SM Collins, H Huang, ... Nature Biotechnology 42 (2), 305-315, 2024 | 17 | 2024 |
| Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells K Qin, P Huang, R Feng, CA Keller, SA Peslak, E Khandros, MS Saari, ... Nature genetics, 1-11, 2022 | 16 | 2022 |
| Molecular basis of polycomb group protein–mediated fetal hemoglobin repression K Qin, X Lan, P Huang, MS Saari, E Khandros, CA Keller, B Giardine, ... Blood, The Journal of the American Society of Hematology 141 (22), 2756-2770, 2023 | 4 | 2023 |
| Heme-Regulated Inhibitor (HRI) Activates Transcription Factor ATF4 to Promote BCL11A Transcription and Fetal Hemoglobin Silencing P Huang, SA Peslak, X Lan, E Khandros, M Sharma, K Qin, CA Keller, ... Blood 134, 814, 2019 | 1 | 2019 |
| B7-H1 blockade improves efficacy of regulatory T cell depletion as cancer immunotherapy by reducing Treg regeneration, possibly through tumor B7-H1 effects (VAC3P. 950) T Curiel, G Sareddy, V Hurez, K Qin, SL Pandeswara, R Vadlamudi, ... The Journal of Immunology 192 (1_Supplement), 73.12-73.12, 2014 | 1 | 2014 |
| Genome-Scale CRISPR-Cas12a Screen Identifies Novel Fetal Hemoglobin Regulators EA Traxler, C Komar, M Saari, AJ Thrasher, K Qin, E Khandros, Q Hotan, ... Blood 142, 1101, 2023 | | 2023 |
| Mechanisms of Polycomb Group Protein-Mediated Fetal Hemoglobin Silencing K Qin, P Huang, X Lan, MS Saari, E Khandros, OY Abdulmalik, CA Keller, ... Blood 140 (Supplement 1), 5382-5383, 2022 | | 2022 |
| Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation Y Wu, K Qin, K Lopez, J Liu, M Nipper, JJ Deng, X Yin, L Ramjit, Z Ye, ... bioRxiv, 2022.05. 31.494216, 2022 | | 2022 |
| Control of Fetal Hemoglobin Levels By NFI Transcription Factors K Qin, P Huang, A Huang, R Feng, T Mayuranathan, CA Keller, ... Blood 136, 54, 2020 | | 2020 |
| Role of Sirtuin 6 in Mouse Pancreatic Beta Cell Development and Homeostasis K Qin The University of Texas Health Science Center at San Antonio, 2018 | | 2018 |
